D. E. Shaw & Co., Inc. Electro Core, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $14,176 - $24,383	-18,902 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.33 - $1.62 $479 - $2,353	-1,453 Reduced 7.14%	18,902 $18,000
Q4 2019 Feb 14, 2020	BUY	$1.23 - $2.67 $1,002 - $2,176	815 Added 4.17%	20,355 $32,000
Q3 2019 Nov 14, 2019	BUY	$1.25 - $5.0 $24,425 - $97,700	19,540 New	19,540 $43,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $523M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.